4
Changes in Ownership
Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014324
Burnett Patrick sold 6,287 shares at an average $25.18 ($158,320)
- Burnett Patrick acquired 46,750 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-08-18 | Grant or award : show line 1 in the form 10b5-1 | +16,750 | 97,401 | D | ||
| 2026-02-27 | Grant or award : show line 2 in the form 10b5-1 | +30,000 | 127,401 | D | ||
| 2026-03-02 | Sale : show line 3 in the form 10b5-1 | −6,106 | $25.16 | $153,629 | 121,295 | D |
| 2026-03-02 | Sale : show line 4 in the form 10b5-1 | −181 | $25.91 | $4,690 | 121,150 | D |
| Open-market sales · 6,287 sh · avg $25.18 · $158,320 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-02-27 | Grant or award : show line 5 in the form 10b5-1 Stock Option (right to buy) | +77,000 | 77,000 | D |
Loading xslF345X05/wk-form4_1772588506.xml…